Treatment of Dry Cough with Unani Medicine Khamira-e-Banafsha.

Phase 2

Not yet recruiting

• Conditions: Cough, (2) ICD-10 Condition: J00-J99||Diseases of the respiratory system,

• Registration Number: CTRI/2018/08/015446
• Lead Sponsor: Central Council for Research in Unani Medicine CCRUM New Delhi

Brief Summary

This study is  a multicentric open trial in patients with **Sual-e-Yabis (Dry Cough)** After screening, Patients will be enrolled if they satisfy inclusion and exclusion criteria.  The patients will be assessed clinically at baseline and after one week.  This includes subjective assessment of general well being and physical examination . The total duration of treatment will be one weeks. . Laboratory parameters for safety assessment will be conducted at baseline and on completion of the protocol therapy.

**Composition of *Khamira-e-Banafsha*:**

| | | | | |

| --- | --- | --- | --- | --- |

|**S.No.**

**Name of the Ingredient**

**Botanical/ English name**

**Part used**

**Quantity**

|

*Gul-e-Banafsha*

*Viola odorata* Linn

Flower

200 gm

|

Aab

Purified water

Liquid

3 ltr

|

Qand-e-Safaid

*Saccharum officianale*

Crystals

1.6 kg

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2018-04-12
• Study Start: 2018-08-24

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 300

Inclusion Criteria

• Patients of either sex in the age group of 18-60 2.
• Sual-e-Yabis (Dry Cough) of < 3 weeks duration.

Exclusion Criteria

• Acute Upper Respiratory Tract Infections (URI or URTI) 2.
• Acute Lower Respiratory Tract Infections (LRI or LRTI) including pneumonia, lung abscess, and acute bronchitis.
• Chronic obstructive airway disease (COAD) including chronic bronchitis and emphysema.
• Bronchiectasis, pulmonary tuberculosis, pulmonary oedema, interstitial pulmonary fibrosis 5.
• Tumours of larynx, bronchi, and lungs 6.
• Diabetes Mellitus, Hypertension 8.
• Known cases of severe hepatic, renal or cardiac ailments 9.
• H/o addiction (smoking, alcohol, drugs) 10.Pregnant and lactating women.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Improvement in sign and symptoms of Sual-e-Yabis (Dry Cough)	One week

Secondary Outcome Measures

Name	Time	Method
Outcome TimePoints	Hematological and biochemical assessments for safety

Trial Locations

Locations (2)

Central Research Institute of Unani Medicine; 🇮🇳 Hyderabad, ANDHRA PRADESH, India

Regional Research Institute of Unani Medicine; 🇮🇳 Aligarh, UTTAR PRADESH, India

Central Research Institute of Unani Medicine

🇮🇳Hyderabad, ANDHRA PRADESH, India

Dr Syed Gulnawaz Ahmad

Principal investigator

9848716693

skgulnawaz@gmail.com